A novel paracetamol 1,000 mg sustained release formulation vs conventional paracetamol 500 mg formulation in patients with fever and pain: a randomized noninferiority trial. [electronic resource]
- Pain medicine (Malden, Mass.) Mar 2013
- 436-41 p. digital